Takeda Hits Lupin With IP Suit Over Acid Reflux Drug
Takeda Pharmaceutical Co. Ltd. on Thursday accused generic-drug maker Lupin Ltd. and a U.S. subsidiary of infringing four of its patents in a suit New Jersey that marks the company's latest...To view the full article, register now.
Already a subscriber? Click here to view full article